Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly Change in Inventory of $581000.0 in Q1 2026, up 151.37% quarter-over-quarter from -$1.1 million in Q4 2025, and up 141.12% on a YoY basis from $240960.7 in Q1 2025.
Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Change in Inventory history runs 9 years deep, the most recent figure standing at $581000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 141.12% year-over-year to $581000.0; the TTM figure through Mar 2026 stood at $7.6 million (up 270.02% YoY), while the FY2025 annual figure was $5.6 million, up 837.57% from the prior year.
- Change in Inventory was $581000.0 for Q1 2026 at Rigel Pharmaceuticals, up from -$1.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $8.4 million in Q2 2025 to a low of -$3.3 million in Q3 2024.
- Historically, Change in Inventory has averaged $391588.2 across 5 years, with a median of -$188000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory soared 1640.18% in 2023, then plunged 1090.04% in 2024.
- A 5-year view of Change in Inventory shows it stood at $2.0 million in 2022, then plunged by 227.63% to -$2.5 million in 2023, then rose by 23.94% to -$1.9 million in 2024, then surged by 41.25% to -$1.1 million in 2025, then soared by 151.37% to $581000.0 in 2026.
- The last three Change in Inventory figures came in at $581000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$188000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | 581,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 581,000.00 |
| Mar 31, 2026 | 581,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Jun 30, 2025 | 8.37 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | -1.41 Mn |
| Mar 31, 2025 | -1.41 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Dec 31, 2023 | -2.53 Mn |